Welcome to LookChem.com Sign In|Join Free
  • or
N-p-carboxyphenyl-β-D-glucosylamine is a chemical compound that consists of a β-D-glucosylamine moiety linked to a p-carboxyphenyl group. N-p-carboxyphenyl-β-D-glucosylamine is a derivative of glucosamine, a naturally occurring amino sugar that plays a significant role in the synthesis of glycosaminoglycans and proteoglycans, which are essential components of cartilage and other connective tissues. The p-carboxyphenyl group adds a carboxylic acid functionality to the molecule, which can participate in various chemical reactions and interactions. N-p-carboxyphenyl-β-D-glucosylamine is often used in the synthesis of complex carbohydrates and as a building block for the development of new pharmaceuticals and biomaterials. Its unique structure allows for the exploration of its potential applications in the fields of drug delivery, enzyme inhibition, and the study of carbohydrate recognition and binding.

4103-32-6

Post Buying Request

4103-32-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4103-32-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4103-32-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,1,0 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4103-32:
(6*4)+(5*1)+(4*0)+(3*3)+(2*3)+(1*2)=46
46 % 10 = 6
So 4103-32-6 is a valid CAS Registry Number.

4103-32-6Relevant academic research and scientific papers

N-glucosides of aminobenzoic acids and aminophenols

Kublashvili

, p. 586 - 588 (2003)

N-o-, -m-, and -p-carboxyphenyl-D-glucosylamines and N-o-, -m-, and -p-hydroxyphenyl-D-glucosylamines were synthesized by reaction of D-glucose with o-, m-, and p-aminobenzoic acids and o-, m-, and p-aminophenols. It was demonstrated that both β- and α-an

Identification of PDZ ligands by docking-based virtual screening for the development of novel analgesic agents

Bouzidi, Naoual,Deokar, Hemantkumar,Vogrig, Alexandre,Boucherle, Benjamin,Ripoche, Isabelle,Abrunhosa-Thomas, Isabelle,Dorr, Liam,Wattiez, Anne-Sophie,Lian, Lu-Yun,Marin, Philippe,Courteix, Christine,Ducki, Sylvie

supporting information, p. 2624 - 2627 (2013/06/27)

Disrupting the interaction between the PDZ protein, PSD-95, and its target ligands (such as the glutamate NMDA receptor or the serotonin 5-HT2A receptor) was found to reduce hyperalgesia in various models of neuropathic pain. Here, we set out to identify lead molecules which would interact with PSD-95, and hence, would potentially display analgesic activity. We describe the virtual screening of the Asinex and Cambridge databases which together contain almost one million molecules. Using three successive docking filters and visual inspection, we identified three structural classes of molecules and synthesized a potential lead compound from each class. The binding of the molecules with the PDZ domains of PSD-95 was assessed by 1H-15N HSQC NMR experiments. The analgesic activity of the best ligand, quinoline 2, was evaluated in vivo in a model of neuropathic pain and showed promising results.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4103-32-6